Syngene International Profile
Key Indicators
- Authorised Capital ₹ 500.00 Cr
- Paid Up Capital ₹ 402.54 Cr
- Company Age 31 Year, 3 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 375.00 Cr
- Satisfied Charges ₹ 1,408.71 Cr
- Revenue Growth 22.99%
- Profit Growth 20.11%
- Ebitda 17.76%
- Net Worth 9.93%
- Total Assets 5.16%
About Syngene International
Syngene International Limited (SIL) is a leading Public Limited Indian Non-Government Company incorporated in India on 18 November 1993 and has a history of 31 years and three months. Its registered office is in Bangaluru, Karnataka, India.
It is listed on the Bombay Stock Exchange(BSE) under the ticker symbol 539268 and on the National Stock Exchange(NSE) under SYNGENE.
The Corporate was formerly known as Syngene International Private Limited. The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 500.00 Cr and a paid-up capital of Rs 402.54 Cr.
The company currently has active open charges totaling ₹375.00 Cr. The company has closed loans amounting to ₹1,408.71 Cr, as per Ministry of Corporate Affairs (MCA) records.
The Key Managerial Personnel (KMP) at Syngene International Limited India are Sibaji Biswas as Cfo, Jonathan Hunt as Ceo, and Priyadarshini Mahapatra as Company Secretary. Vinita Bali, Kiran Shaw, Nilanjan Roy, and Seven other members serve as directors at the Company.
Company Details
- Location
Bangaluru, Karnataka, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
- Social Media
Corporate Identity Details
Industry
Who are the key members and board of directors at Syngene International?
Executive Team (3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Priyadarshini Mahapatra  | Company Secretary | 24-Jul-2019 | Current |
Jonathan Hunt  | Managing Director | 01-May-2017 | Current |
| Sibaji Biswas | CFO | 18-Dec-2019 | Current |
Board Members (9)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Vinita Bali | Director | 31-Jul-2017 | Current |
Vijay Kuchroo  | Director | 01-Mar-2017 | Current |
| Sharmila Karve | Director | 01-Aug-2019 | Current |
| Kiran Shaw | Director | 18-Nov-1993 | Current |
Catherine Rosenberg  | Director | 08-Aug-2000 | Current |
| Nilanjan Roy | Director | 30-Apr-2024 | Current |
Financial Performance of Syngene International.
Syngene International Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 22.99% increase. The company also saw a substantial improvement in profitability, with a 20.11% increase in profit. The company's net worth moved up by a moderate rise of 9.93%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Syngene International?
In 2023, Syngene International had a promoter holding of 54.88% and a public holding of 45.12%. The company had 2 Subsidiaries. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Vanaz Engineers LimitedSharmila Karve is a mutual person
Science Gallery BengaluruKiran Shaw is a mutual person
Mazumdar Shaw Medical FoundationKiran Shaw is a mutual person
Immuneel Therapeutics Private LimitedKiran Shaw is a mutual person
Thomas Cook (India) LimitedSharmila Karve is a mutual person
Csb Bank LimitedSharmila Karve is a mutual person
Charges (Loans)
₹375.00 Cr
₹1,408.71 Cr
Charges Breakdown by Lending Institutions
- Others : 375.00 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 30 Mar 2021 | Others | ₹375.00 Cr | Open |
| 03 Aug 2021 | Others | ₹370.03 Cr | Satisfied |
| 15 Sep 2016 | Others | ₹670.00 Cr | Satisfied |
| 28 Feb 2011 | The Bank Of Nova Scotia | ₹50.00 Cr | Satisfied |
| 27 Sep 2008 | State Bank Of India | ₹10.00 Cr | Satisfied |
How Many Employees Work at Syngene International?
Syngene International has a workforce of 5834 employees as of Mar 21, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Syngene International, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Syngene International's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
